
Evotec SE (EVO) Stock Forecast & Price Target
Evotec SE (EVO) Analyst Ratings
Bulls say
Evotec is supported by a clear sequential recovery in D&PD, with 3Q26 revenue of €164.9M up 14.9% QoQ and 9M26 revenue of €465.0M, while D&PD base-business orders rose 24% YoY and are now converting into revenue, especially in Discovery and Cyprotex. Cost actions are also strengthening the investment case, as the 3Q26 adjusted EBITDA loss narrowed to €1.6M from €15.0M a year earlier, gross margin expanded to 12.0%, and more than €15M of annualized savings had already been delivered by end-September toward the €15–22.5M FY26 target. Longer term, the approximately €1B revenue ambition for 2030 is backed by a diversified mix across D&PD, strategic partnerships, and JEB, while cash and cash equivalents of €299.0M and total liquidity of €400.9M provide a solid balance-sheet cushion.
Bears say
Evotec is facing a weakened fundamental outlook after cutting FY2026 revenue guidance to €570M-€610M from €700M-€780M, while adjusted EBITDA shifted from €0M to +€40M to a loss of €70M to €105M, signaling a sharper earnings deterioration than expected. The company’s lower outlook is driven by delayed milestone timing across partnerships, slower-than-expected conversion of new strategic deals in D&PD, and weaker sales-to-revenue conversion, all of which undermine visibility and leave its high fixed-cost base exposed to margin compression. Although liquidity improved to €465.6M as of June 30, 2026 and net cash was about €35M at the end of 2Q26, preliminary 2Q26 revenue of €143.5M still fell short of consensus, reinforcing the negative view on execution and near-term growth.
This aggregate rating is based on analysts' research of Evotec SE and is not a guaranteed prediction by Public.com or investment advice.
Evotec SE (EVO) Analyst Forecast & Price Prediction
Start investing in Evotec SE (EVO)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Evotec SE (EVO) Forecast
Evotec SE (EVO) Analyst Forecast & Price Prediction
Start investing in Evotec SE (EVO)
Order type
Buy in
Order amount
Est. shares
0 shares